Skip to content

NCEL

NewCelX Ltd.

NASDAQ · Healthcare · Biotechnology · CH

$3.15
−6.80%
Ask drillr

Margins

Gross margin
EBITDA margin
EBIT margin
Net margin
FCF margin
29.3%
Return on equity
18.6%
Return on assets
-77.3%
Return on invested capital
0.00x
Asset turnover
-$2.1M
Cash from operations
$0.41
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026